当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析

华森制药

(002907)

  

流通市值:51.05亿  总市值:71.07亿
流通股本:3.00亿   总股本:4.18亿

华森制药(002907)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.52亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益170885.84万元,未分配利润71470.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产202073.30万元,负债31187.46万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入441,913,009.17238,944,153.42774,819,866.89614,223,361.57
营业总成本385,855,057.45189,330,193.11699,830,140.66534,304,062.41
其他经营收益
营业利润75,512,477.6149,521,445.8993,800,589.589,054,863.38
利润总额62,122,793.4649,301,337.6293,441,938.6988,672,868.81
净利润52,286,443.0240,355,212.3876,730,225.1274,576,835.63
每股收益
其他综合收益-17,736.58-6,070.86244,061.74-173,845.46
综合收益总额52,268,706.4440,349,141.5276,974,286.8674,402,990.17
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,088,649,343.411,091,355,563.011,031,344,511.281,013,977,367.68
非流动资产:
非流动资产合计932,083,668.02862,206,829.46886,205,077.72897,738,929.78
资产总计2,020,733,011.431,953,562,392.471,917,549,5891,911,716,297.46
流动负债:
流动负债合计256,630,165.59209,944,378.22212,034,140.92207,532,333.4
非流动负债:
非流动负债合计55,244,436.1743,120,927.1545,517,169.746,906,649.57
负债合计311,874,601.76253,065,305.37257,551,310.62254,438,982.97
所有者权益(或股东权益):
归属于母公司股东权益合计1,684,759,062.71,700,497,087.11,659,998,278.381,657,277,314.49
股东权益合计1,708,858,409.671,700,497,087.11,659,998,278.381,657,277,314.49
负债和股东权益合计2,020,733,011.431,953,562,392.471,917,549,5891,911,716,297.46
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计423,898,088.77191,675,253.51799,973,405.6592,150,956.57
经营活动现金流出小计396,371,750.13169,814,310.46638,206,596.58485,270,379.52
经营活动产生的现金流量净额27,526,338.6421,860,943.05161,766,809.02106,880,577.05
投资活动产生的现金流量:
投资活动现金流入小计231,781,185.5121,203,411.52348,531,606.4214,694,231.3
投资活动现金流出小计404,232,394.94302,374,756.73455,741,063.7452,000,526.19
投资活动产生的现金流量净额-172,451,209.44-181,171,345.21-107,209,457.3-237,306,294.89
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计26,943,089.8728,80035,634,044.7235,634,044.72
筹资活动产生的现金流量净额-26,943,089.87-28,800-35,634,044.72-35,634,044.72
汇率变动对现金及现金等价物的影响-131,580.48-136,374.9563,769.26-45,680.88
现金及现金等价物净增加额-171,999,541.15-159,475,577.1118,987,076.26-166,105,443.44
期末现金及现金等价物余额284,552,354.25297,077,352.27456,551,895.4271,459,375.7
补充资料:
现金及现金等价物的净增加额-171,999,541.15-18,987,076.26-
TOP↑